Ainos, Inc. Signs Material Definitive Agreement
Ticker: AIMDW · Form: 8-K · Filed: Oct 22, 2024 · CIK: 1014763
| Field | Detail |
|---|---|
| Company | Ainos, INC. (AIMDW) |
| Form Type | 8-K |
| Filed Date | Oct 22, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01, $50,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, corporate-update
TL;DR
Ainos Inc. just signed a big deal, could be good news.
AI Summary
On October 16, 2024, Ainos, Inc. entered into a Material Definitive Agreement. The company, formerly known as Amarillo Biosciences Inc., is incorporated in Texas and its principal executive offices are located in San Diego, California.
Why It Matters
This filing indicates a significant new contract or partnership for Ainos, Inc., which could impact its future business operations and financial performance.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement can introduce new risks and opportunities, the specifics of which are not detailed in this initial filing.
Key Players & Entities
- Ainos, Inc. (company) — Registrant
- October 16, 2024 (date) — Date of earliest event reported
- Texas (jurisdiction) — State of Incorporation
- San Diego, CA (location) — Principal Executive Offices
- Amarillo Biosciences Inc. (company) — Former Company Name
FAQ
What is the nature of the Material Definitive Agreement entered into by Ainos, Inc.?
The filing does not specify the details of the Material Definitive Agreement, only that one was entered into on October 16, 2024.
When was the Material Definitive Agreement signed?
The Material Definitive Agreement was entered into on October 16, 2024.
What is Ainos, Inc.'s state of incorporation?
Ainos, Inc. is incorporated in Texas.
Where are Ainos, Inc.'s principal executive offices located?
Ainos, Inc.'s principal executive offices are located at 8880 Rio San Diego Drive, Ste. 800, San Diego, CA 92108.
What was Ainos, Inc.'s former company name?
Ainos, Inc.'s former company name was Amarillo Biosciences Inc.
Filing Stats: 686 words · 3 min read · ~2 pages · Grade level 11.9 · Accepted 2024-10-22 16:15:23
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share AIMD The Nasdaq Stock Mar
- $50,000 — ned in the Third Addendum Agreement, is $50,000 per month (plus 5% sales tax) for one y
Filing Documents
- form8-k.htm (8-K) — 42KB
- ex10-1.htm (EX-10.1) — 19KB
- 0001493152-24-042062.txt ( ) — 282KB
- aimd-20241016.xsd (EX-101.SCH) — 4KB
- aimd-20241016_def.xml (EX-101.DEF) — 29KB
- aimd-20241016_lab.xml (EX-101.LAB) — 36KB
- aimd-20241016_pre.xml (EX-101.PRE) — 26KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Ainos, Inc. Date: October 22, 2024 By: /s/ Chun-Hsien Tsai Name: Chun-Hsien Tsai Title: Chief Executive Officer 3